Open AccessPharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers
Author(s) -
Akil Jackson,
Antonio D’Avolio,
Victoria Watson,
Stefano Bonora,
D.J. Back,
J. Andrew Taylor,
K. Armenis,
Brian Gazzard,
Graeme Moyle,
Marta Boffito
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq546
Subject(s) - raltegravir , ezetimibe , pharmacokinetics , pharmacology , medicine , drug , antiretroviral drug , elvitegravir , human immunodeficiency virus (hiv) , antiretroviral therapy , cholesterol , virology , viral load
To assess the pharmacokinetics (PK) of raltegravir and ezetimibe when co-administered to healthy volunteers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom